Testing effectiveness (Phase 2)Ended earlyNCT05312697
What this trial is testing
Long-term Extension Study of Setrusumab in Adults With Type I, III, or IV Osteogenesis Imperfecta
Who this might be right for
Osteogenesis Imperfecta
Ultragenyx Pharmaceutical Inc 2